Sunshine Biopharma Inc (SBFM)

[Reters]

Pretty simple analysis here;
-SBFM owed $17mill for the patents they aquired, debt was a burden on funding negotiations.
-SBFM just cleared their debt overhang, by issuing shares 400% above current market price. Therefor as of yesterday, they reduced their purchase price from $17mill to $3.5mill A SAVINGS of $13.5Mill!!!
-SBFM current O/S is 150mill and A/S is 250mill. There is not enough room above to issue these extra 321mill shares so they have increased the A/S to 3bill.
-But why 3bill? Any financing will include shares, they need many million $ to finance this drug from Phase1 - Phase3 - Market.
-This is not a company that can operate bootstraped, they need to issue shares in exchange for $. How else would they raise $?
-Now that the authorize has been upped and the debts been wiped away they can actually get the financing theyve been going after.